Nordic Stocks: Autoliv, Boliden, Maersk, Novo Nordisk, Yara

The Stoxx Nordic 30 Index, the benchmark measure for the region, fell less than 0.1 percent to 7,686.10 at the 5:30 p.m. close in Copenhagen, retreating for a second day.

The OMX Helsinki 25 Index declined 0.5 percent. Norway’s OBX Index rose 0.5 percent while the Copenhagen 20 Index rose less than 0.1 percent. The OMX Stockholm 30 Index closed 1.2 percent lower as trading stopped at 1 p.m. local time for a half-day public holiday in Sweden.

The following shares were among the most active in Nordic markets today. Symbols are in parentheses.

A.P. Moeller-Maersk A/S (MAERSKB DC) fell for the first day this week, losing 2.4 percent to 51,600 kroner. Societe Generale SA cut its price estimate for the shares in Denmark’s biggest company to 69,000 kroner from 72,000 kroner, according to Bloomberg data.

Autoliv Inc. (ALIV SS) slumped the most since Dec. 27, losing 2.2 percent to 534 kronor. The world’s largest maker of automotive air bags was cut to “hold” from “buy” at SEB AB, which said it sees “limited support for the shares to continue to outperform.”

Boliden AB (BOL SS) fell the most since Nov. 23, declining 2.9 percent to close at 137 kronor. Exane BNP Paribas cut its recommendation on the Swedish copper and zinc miner to “underperform” from “neutral.”

Novo Nordisk A/S (NOVOB DC) rose to the highest price on record, gaining 2.3 percent to 653 kroner. Jyske Bank A/S lifted its price estimate for the shares in the world’s largest maker of insulin to 675 kroner from 650 kroner, according to Bloomberg data.

Yara International ASA (YAR NO) rose for the first day this week, adding 0.9 percent to 333.8 kroner. The world’s largest publicly traded nitrogen-fertilizer maker said rising asset prices haven’t curbed its expansion plans.

To contact the reporters on this story: Adam Ewing in Stockholm at; Christian Wienberg in Copenhagen at

To contact the editor responsible for this story: David Merritt at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.